Sprouts Farmers Market, Inc. (SFM): what the price assumes

boothcheck covers Sprouts Farmers Market, Inc. (SFM) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-28.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/SFM

Headline

FieldValue
TickerSFM
CompanySprouts Farmers Market, Inc.
Current price$85.12/sh
CompositionPerishables 57% / Non-Perishables 43%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)0.9%
Operating margin today7.4%
Margin compression (value-band)-6.5pp
Multiple paid15x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage.

Reconcile: at the x-ray's 9.3% required return this reads ~6.9%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.95σ
cohort percentile (of 69 peers)22
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.48x5expensive
Earnings1.51x3expensive
Relative0.88x5justifies
Growth0.73x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.4%); the inversion above states its own rate.

Per-Model Detail (n=16)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$116.040.73xyesFCF base $0.4B, growth 7% (input: historical growth), terminal g 4.0%, WACC 7.4%, 6yr projection
DCF Exit MultipleGrowth$118.790.72xyesExit EV/EBITDA: 12.1x / 14.1x / 16.1x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$105.080.81xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.3x / 22.0x / 25.7x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$57.581.48xyesBV/sh $15.90, ROE (TTM) 33.5%, ke 9.3%
Two-Stage Excess ReturnAsset$115.760.74xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$90.000.95xyesRev $9.0B, growth 7% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.9x / 1.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$64.401.32xyesEPS $5.23, growth 12% (input: historical EPS growth), PEG=1.30 (Fair)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$15.075.65xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.49B × (1−26%) / WACC 7.4% → EPV (no growth)
Residual IncomeAsset$89.210.95xyesBV $15.90 + 5yr PV of (ROE (TTM) 33.5% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$43.251.97xyes√(22.5 × EPS $5.23 × BVPS $15.90) — Graham's conservative floor
EV/EBITDA RelativeRelative$84.321.01xyesEBITDA $0.84B × sector EV/EBITDA 14.0x
FCF YieldEarnings$0.37230.05xyesFCF $356.8M / Kₑ 9.3% — zero-growth perpetuity (excluded from median)
SBC-Adj FCF YieldEarnings$0.018512.00xyesSBC-adj FCF $0.32B (FCF $0.36B − SBC $0.03B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarnings$145.200.59xyesEPS $5.23 × (8.5 + 2×12.3%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$5.2216.31xyesBV $15.90 × (ROIC 2.4% / WACC 7.4%)
P/Sales SectorRelative$190.740.45xyesRevenue $9.00B × sector P/S 2.0x
PEG Fair ValueRelative$96.600.88xyesEPS $5.23 × (PEG 1.5 × growth 12.3% (input: historical EPS growth)) → PE 18.5x
Earnings YieldEarnings$56.541.51xyesEPS $5.23 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$210.7m
Net debt / NOPAT (after-tax)-0.42x (net cash)
Net debt / operating income (pre-tax)-0.31x (net cash)
Share count CAGR (buyback)-3.7%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

Sprouts funds its own growth, which is the unglamorous foundation of the whole thesis. The company carries net cash of about $239 million against almost no debt, generates roughly $362 million of free cash flow, and has shrunk its share count nearly 4% a year through buybacks. That combination, expansion paid for from internal cash while shares retire, is rare in grocery, a business usually defined by thin margins and heavy capital needs. It lets Sprouts open more than 40 stores a year without leaning on debt or dilution, and it returns the excess to owners on top.

The returns the business earns on that capital are exceptional for a grocer. Return on equity runs around 35%, on a book value of just $15 per share, because Sprouts operates a differentiated, high-velocity format rather than a commodity supermarket. Its own filing describes the targeting precisely: the company has built its strategy around "health enthusiasts and selective shoppers" and tells "our unique and differentiated story" to those customers. That focus on attribute-rich, fresh-heavy, health-oriented assortment is what supports a gross margin near 39.4%, far above a conventional grocer, and it is the reason new stores ramp into a profitable footprint.

The growth runway is real and self-evident in the store count: 483 locations across 25 states after six openings in the first quarter, with management guiding to over 40 new stores in 2026. Against today's $80.51 (June 28, 2026), the forward-growth methods land well above the price, and the peer-multiple lens reads the price at roughly three-quarters of the sector earnings multiple. The market is paying for a grocer's growth at less than a grower's multiple, while the company compounds book value at a high return and buys back stock. For a self-funding, high-return, still-expanding format, the forward methods, not the no-growth floor, are reading the price.

Bear Case

The external variable with the most leverage over Sprouts is the one it least controls: the discretionary health-conscious consumer, and that consumer just slowed. Comparable store sales fell 1.7% in the first quarter of 2026, and management guided full-year comps to a range of -1% to +1%, with the second quarter pointed at -2% to 0%. After a stretch of strong comps, the deceleration is the story. Sprouts sells premium, specialty groceries, and that basket is exactly what shoppers trim when budgets tighten or when they trade down to conventional chains. The company's own filing names the exposure, warning that comparable store sales growth "could be lower than our historical average" due to "general economic conditions, competition, cycling prior year performance". Cycling prior-year performance is precisely what is happening now.

The profit picture softened alongside the comps. Diluted EPS slipped to $1.71 from $1.81 a year earlier, and gross margin fell 20 basis points to 39.4% on loyalty investments and shrink. The growth story has been carrying the multiple; when the comps that signal underlying demand turn negative, the market reweights toward the slower, store-count-driven growth, which is lower quality than same-store momentum. New stores also dilute near-term margins, since the filing notes they "generally have lower margins and higher" costs in their initial period, so an acceleration in openings can pressure the consolidated margin before it helps.

The valuation is where the risk concentrates. The earnings-power lens already calls the price expensive, valuing the current profit with no growth far below the price. The bull case rests entirely on continued growth, and the methods that justify the price are exactly the forward-growth ones. That makes Sprouts a durability bet: if comps stay negative and the premium-grocery demand keeps softening, the growth premium the price pays compresses toward the no-growth floor. The balance sheet is pristine, so this is not a solvency risk. It is a multiple risk on a high-quality grower whose same-store growth, the cleanest signal of the thesis, has turned the wrong way.

Valuation

Sprouts is priced as a grower, and the valuation question is whether the growth holds. The whole-company operating margin runs about 7.6%, strong for grocery, and inverted, today's price requires only a modest margin to be sustained, so the priced-in assumption sits within the range the business supports rather than at a stretch.

The method families split along the growth line. The forward-growth lenses, the discounted-cash-flow reads and the future-market-cap model, land well above the price by crediting continued store and revenue growth, and the peer-multiple lens reads the price at roughly three-quarters of the sector earnings multiple. Against them, the earnings-power lens calls the price expensive, capitalizing the current profit with no growth to a value far below the price, and the asset-based excess-return read also sits below the price on a book value of $15 per share. The pattern is a name justified by growth and relative-multiple value: the methods that credit the expansion say supported or cheap, while the method that assumes the company stops growing says expensive. The cleanest cross-check is the return on equity near 35%, which is what lets Sprouts grow book value quickly and is the reason the forward methods reach the price; the no-growth floor ignores that compounding by construction.

Solvency is essentially a non-issue and frees the balance sheet to fund growth and buybacks at once. Net cash of about $239 million, negligible debt, roughly $362 million of free cash flow, and a share count falling near 4% a year describe a company returning capital while it expands. The risk is not the balance sheet; it is demand. With first-quarter comparable sales down 1.7% and full-year comps guided around flat, the question the price asks the buyer to answer is whether the new-store growth and the premium-format loyalty hold up as the discretionary grocery shopper turns cautious. That, not any leverage concern, decides whether the growth methods or the no-growth floor are reading the price correctly.

Catalysts

Sprouts' first quarter of 2026 showed growth slowing from a high base. Net sales rose 4% to $2.33 billion, driven by new stores, but comparable store sales fell 1.7% and diluted EPS slipped to $1.71 from $1.81 a year earlier, with gross margin down 20 basis points to 39.4% on loyalty investments and shrink. The company opened six stores in the quarter to reach 483 across 25 states. EBIT was $215 million at a 9.2% margin.

Guidance set the bar for the rest of the year. For full-year 2026, Sprouts targets net sales growth of 4.5% to 6.5%, comparable store sales between -1% and +1%, EBIT of $675 million to $695 million, diluted EPS of $5.32 to $5.48, and over 40 new stores, with second-quarter comps guided to -2% to 0% and EPS of $1.32 to $1.36. The central event to watch is the comp trajectory: the full-year range straddles flat, so each quarterly print signals whether the premium-grocery shopper is stabilizing or continuing to pull back. The store-opening cadence is the offsetting growth lever, but same-store sales are the line that determines how the market values the growth.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings, April 2026 · Q1 2026 guidance, April 2026

View the full interactive SFM report on boothcheck